Data Bridge Market Research forecasts growth in thrombectomy devices and orchitis treatment markets

Data Bridge Market Research reports that the global thrombectomy devices market was valued at about USD 1.3 billion in 2022 and is projected to reach roughly USD 2.06 billion by 2030, representing a compound annual growth rate (CAGR) of 5.9% over the 2023‑2030 period. The market is segmented by type – mechanical thrombectomy devices, aspiration catheters, stent retrievers and others – and by application, covering cardiovascular and neurovascular uses, with hospitals and ambulatory surgical centers as the primary end‑users.

The same firm estimates the global orchitis treatment market at USD 1.89 billion in 2024, with an expected increase to about USD 2.9 billion by 2032, reflecting a CAGR of 5.5%. This market is divided by type of orchitis (bacterial, viral, chronic, others), treatment modality (medication, surgery, other), and end‑user (hospitals, clinics, ambulatory surgical centers). Distribution channels include hospital pharmacies, retail pharmacies and online pharmacies, the latter projected to grow rapidly.